Shopping Cart 0
Cart Subtotal
AED 0

TransGenic Inc (2342) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

TransGenic Inc (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The products and services of the company include knockout mouse and phenotype database, genetically engineered mice, custom production of knock out mouse, custom production of antibodies and proteins, drug discovery and support services, contract services for non-clinical study, mouse related products and antibody related products. The company has two fundamental technologies, namely, Exchangeable Gene-trap Method to destroy genes of a mouse and GANP Mouse to produce high-affinity antibodies. TransGenic is headquartered in Chuo-ku, Fukuoka City, Japan.

TransGenic Inc (2342)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TransGenic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TransGenic Inc, Medical Devices Deals, 2012 to YTD 2018 9

TransGenic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TransGenic Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

TransGenic To Acquire Clinical Trial Business Of New Drug Development Research Center For USD 2 Million 11

Partnerships 12

TransGenic Enters into Research Agreement with Immuno-Biological Labs 12

Licensing Agreements 13

TransGenic Enters into Licensing Agreement with University of Tokyo 13

Trans Genic Enters into Licensing Agreement with National Institute of Advanced Industrial Science and Technology 14

TransGenic Enters into Licensing Agreement with Osaka City University 15

Equity Offering 16

Immuno-Biological Labs Raises USD1.8 Million in Private Placement of Shares 16

Trans Genic Raises USD0.6 Million in Private Placement of Shares 17

Debt Offering 18

Trans Genic Raises USD1.6 Million in Private Placement of Bonds and Warrants 18

Acquisition 19

TransGenic to Sell its 30% Stake in Kobe-Based Medicine Company 19

TransGenic Inc-Key Competitors 20

TransGenic Inc-Key Employees 21

TransGenic Inc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Strategy And Business Planning 23

Nov 15, 2017: TRANS GENIC to Launch New Business (New Subsidiary Company) 23

Product News 25

Aug 01, 2017: TRANS GENIC Group to Launch Non-Clinical Test Service Using Mice Models of Central Nervous System Diseases 25

Other Significant Developments 26

Feb 06, 2018: New Drug Research Center to Launch Non-Clinical Test Service Using Mouse Model of Atopic Dermatitis 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TransGenic Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

TransGenic Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TransGenic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TransGenic Inc, Deals By Therapy Area, 2012 to YTD 2018 8

TransGenic Inc, Medical Devices Deals, 2012 to YTD 2018 9

TransGenic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TransGenic To Acquire Clinical Trial Business Of New Drug Development Research Center For USD 2 Million 11

TransGenic Enters into Research Agreement with Immuno-Biological Labs 12

TransGenic Enters into Licensing Agreement with University of Tokyo 13

Trans Genic Enters into Licensing Agreement with National Institute of Advanced Industrial Science and Technology 14

TransGenic Enters into Licensing Agreement with Osaka City University 15

Immuno-Biological Labs Raises USD1.8 Million in Private Placement of Shares 16

Trans Genic Raises USD0.6 Million in Private Placement of Shares 17

Trans Genic Raises USD1.6 Million in Private Placement of Bonds and Warrants 18

TransGenic to Sell its 30% Stake in Kobe-Based Medicine Company 19

TransGenic Inc, Key Competitors 20

TransGenic Inc, Key Employees 21

TransGenic Inc, Other Locations 22

TransGenic Inc, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

TransGenic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

TransGenic Inc (TransGenic) is a biotechnology company which develops and distributes genetically engineered animals and antibodies and licensing of these activities. The products and services of the company include knockout mouse and phenotype database, genetically engineered mice, custom production of knock out mouse, custom production of antibodies and proteins, drug discovery and support services, contract services for non-clinical study, mouse related products and antibody related products. The company has two fundamental technologies, namely, Exchangeable Gene-trap Method to destroy genes of a mouse and GANP Mouse to produce high-affinity antibodies. TransGenic is headquartered in Chuo-ku, Fukuoka City, Japan.

TransGenic Inc (2342)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TransGenic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TransGenic Inc, Medical Devices Deals, 2012 to YTD 2018 9

TransGenic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TransGenic Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

TransGenic To Acquire Clinical Trial Business Of New Drug Development Research Center For USD 2 Million 11

Partnerships 12

TransGenic Enters into Research Agreement with Immuno-Biological Labs 12

Licensing Agreements 13

TransGenic Enters into Licensing Agreement with University of Tokyo 13

Trans Genic Enters into Licensing Agreement with National Institute of Advanced Industrial Science and Technology 14

TransGenic Enters into Licensing Agreement with Osaka City University 15

Equity Offering 16

Immuno-Biological Labs Raises USD1.8 Million in Private Placement of Shares 16

Trans Genic Raises USD0.6 Million in Private Placement of Shares 17

Debt Offering 18

Trans Genic Raises USD1.6 Million in Private Placement of Bonds and Warrants 18

Acquisition 19

TransGenic to Sell its 30% Stake in Kobe-Based Medicine Company 19

TransGenic Inc-Key Competitors 20

TransGenic Inc-Key Employees 21

TransGenic Inc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Strategy And Business Planning 23

Nov 15, 2017: TRANS GENIC to Launch New Business (New Subsidiary Company) 23

Product News 25

Aug 01, 2017: TRANS GENIC Group to Launch Non-Clinical Test Service Using Mice Models of Central Nervous System Diseases 25

Other Significant Developments 26

Feb 06, 2018: New Drug Research Center to Launch Non-Clinical Test Service Using Mouse Model of Atopic Dermatitis 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TransGenic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TransGenic Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

TransGenic Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TransGenic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TransGenic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TransGenic Inc, Deals By Therapy Area, 2012 to YTD 2018 8

TransGenic Inc, Medical Devices Deals, 2012 to YTD 2018 9

TransGenic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TransGenic To Acquire Clinical Trial Business Of New Drug Development Research Center For USD 2 Million 11

TransGenic Enters into Research Agreement with Immuno-Biological Labs 12

TransGenic Enters into Licensing Agreement with University of Tokyo 13

Trans Genic Enters into Licensing Agreement with National Institute of Advanced Industrial Science and Technology 14

TransGenic Enters into Licensing Agreement with Osaka City University 15

Immuno-Biological Labs Raises USD1.8 Million in Private Placement of Shares 16

Trans Genic Raises USD0.6 Million in Private Placement of Shares 17

Trans Genic Raises USD1.6 Million in Private Placement of Bonds and Warrants 18

TransGenic to Sell its 30% Stake in Kobe-Based Medicine Company 19

TransGenic Inc, Key Competitors 20

TransGenic Inc, Key Employees 21

TransGenic Inc, Other Locations 22

TransGenic Inc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

TransGenic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.